1097263-60-9

Bosentan USP RC C Bosentan Impurity C Bosentan Related CoMpound C Bosentan USP Related Compound C 1,2-bis({6-[4-(tert-Butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane N,N-((ethane-1,2-diylbis(oxy))bis(5-(2-methoxyphenoxy)-[2,2-bipyrimidine]-6,4-diyl))bis(4-(tert-butyl)benzenesulfonamide) N,N'-[1,2-Ethanediylbis[oxy[5-(2-methoxyphenoxy)[2,2'-bipyrimidine]-6,4-diyl]]]bis[4-(1,1-dimethylethyl)benzenesulfonamide] BenzenesulfonaMide, N,N'-[1,2-ethanediylbis[oxy[5-(2-Methoxyphenoxy)[2,2'-bipyriMidine]-6,4-diyl]]]bis[4-(1,1-diMethylethyl)- N,N'-(6,6''-(ethane-1,2-diylbis(oxy))bis(5-(2-methoxyphenoxy)-[2,2'-bipyrimidine]-6,4-diyl))bis(4-(tert-butyl)benzenesulfonamide) Bosentan USP Related Compound C: 1,2-Bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]4-yl}oxy)ethane Bosentan Related Compound C (15 mg) (1,2-bis({6-[4-(tert-butyl)phenylsulfonamido]-5-(2-methoxyphenoxy)-[2,2'-bipyrimidin]-4-yl}oxy)ethane)